Contracts › W81K0023P0091
W81K0023P0091: Cancer Antibodies Reagents
Awarded to Roche Diagnostics Corporation by Department of the Army.
$1.1Mobligated
$2.0Mpotential value
30 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | W81K0023P0091 |
|---|---|
| Awardee | Roche Diagnostics Corporation |
| Awarding agency | Department of the Army |
| Awarding office | W40M MRC0 WEST |
| NAICS | 339112 Surgical and Medical Instrument Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | IN |
| Offers received | 1 |
| Period of performance | 01 October 2023 to 30 September 2026 |
| Potential end | 30 September 2028 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 339112 contracts · All expiring contracts · USASpending record